157 related articles for article (PubMed ID: 1313157)
21. Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats.
Rahmani NH; Gulati A; Bhargava HN
Peptides; 1990; 11(4):693-5. PubMed ID: 2172939
[TBL] [Abstract][Full Text] [Related]
22. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
Bhargava HN; Thorat SN
Brain Res; 1993 Oct; 625(1):120-4. PubMed ID: 8242390
[TBL] [Abstract][Full Text] [Related]
23. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse.
Bhargava HN; Cao YJ
Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726
[TBL] [Abstract][Full Text] [Related]
24. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
Bhargava HN
Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
[TBL] [Abstract][Full Text] [Related]
25. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
Sharif NA
Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
[TBL] [Abstract][Full Text] [Related]
26. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
Bhargava HN; Das S; Bansinath M; Prasad R
Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
Bhargava HN; Gulati A
Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
[TBL] [Abstract][Full Text] [Related]
28. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
29. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
Bhargava HN; Gulati A
Pharmacology; 1988; 37(6):349-55. PubMed ID: 2854272
[TBL] [Abstract][Full Text] [Related]
30. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
Bhargava HN; Matwyshyn G; Ramarao P
Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
[TBL] [Abstract][Full Text] [Related]
31. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
Yamamoto T; Ohno M; Ueki S
Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
[TBL] [Abstract][Full Text] [Related]
32. Limbic brain structures are important sites of kappa-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study.
Ableitner A; Herz A
Brain Res; 1989 Jan; 478(2):326-36. PubMed ID: 2538203
[TBL] [Abstract][Full Text] [Related]
33. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
[TBL] [Abstract][Full Text] [Related]
34. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
Takahashi M; Senda T; Kaneto H
Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
[TBL] [Abstract][Full Text] [Related]
35. Effect of multiple injections of U-50, 488H, a kappa-opioid receptor agonist, on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
Bhargava HN; Kumar S
Gen Pharmacol; 1997 Sep; 29(3):397-9. PubMed ID: 9378246
[TBL] [Abstract][Full Text] [Related]
36. Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.
Bhargava HN; Gulati A; Rahmani NH
Eur J Pharmacol; 1991 Sep; 202(3):403-8. PubMed ID: 1660817
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
Bhargava HN
Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
[TBL] [Abstract][Full Text] [Related]
38. Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors.
Bhargava HN; Ramarao P; Gulati A
Prog Clin Biol Res; 1990; 328():153-6. PubMed ID: 2406759
[No Abstract] [Full Text] [Related]
39. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
Czlonkowski A; Millan MJ; Herz A
Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
[No Abstract] [Full Text] [Related]
40. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
